Prognostic significance of tumor tissue NeuGcGM3 ganglioside expression in patients receiving racotumomab immunotherapy
![Thumbnail](/xmlui/bitstream/handle/20.500.12511/5744/Ayla%2c%20Sule-2020.pdf.jpg?sequence=9&isAllowed=y)
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessAttribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/Tarih
2020Yazar
Üskent, NecdetAyla, Şule
Molinas Mandel, Nil
Özkan, Metin
Teomete, Mehmet
Baloğlu, Hüseyin
Aydinçer, Cenk
Yergök, Hale
Doğan, Ender
Berk, Barkın
Yazar, Aziz
Üst veri
Tüm öğe kaydını gösterKünye
Üskent, N., Ayla, Ş., Molinas Mandel, N., Özkan, M., Teomete, M., Baloğlu, H. ... Yazar, A. (2020). Prognostic significance of tumor tissue NeuGcGM3 ganglioside expression in patients receiving racotumomab immunotherapy. Journal of Oncology, 2020. https://dx.doi.org/10.1155/2020/1360431Özet
Expression ofN-glycolyl GM3 (NeuGcGM3) ganglioside was detected in the tumor specimens of patients who were on Racotumomab anti-idiotype vaccine maintenance treatment, and prognostic significance as a biomarker was investigated. No statistically significant association was observed in the multivariate analysis between overall survival and tissue NeuGcGM3 IHC levels. Although numerically there was a difference favoring less intense IHC for better prognosis, this did not reach statistical power. However, there was a strong correlation between Racotumomab doses and overall survival (OS). Mean OS of the patient with more than 10 Racotumomab application was significantly longer than the patient who had less than 10 injections (70.7 months vs. 31.1 months, p<0.001). We propose that, regardless of staining intensity, the presence of NeuGcGM3 in patient tissues might be an indicator of benefit in Racotumomab treatment.
WoS Q Kategorisi
Q2Scopus Q Kategorisi
Q2Kaynak
Journal of OncologyCilt
2020Koleksiyonlar
- Makale Koleksiyonu [284]
- Makale Koleksiyonu [3790]
- PubMed İndeksli Yayınlar Koleksiyonu [4251]
- Scopus İndeksli Yayınlar Koleksiyonu [6601]
- WoS İndeksli Yayınlar Koleksiyonu [6677]
Aşağıdaki lisans dosyası bu öğe ile ilişkilidir: